Absence of Myocardial Fibrosis Predicts Favorable Long-Term Survival in New-Onset Heart Failure

Myocardial fibrosis, identified by late gadolinium enhancement cardiovascular magnetic resonance, predicts outcomes in chronic heart failure (HF). Its prognostic significance in new-onset HF and reduced left ventricular ejection fraction (LVEF) is unclear. We investigated whether the pattern and ext...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation. Cardiovascular imaging 2018-09, Vol.11 (9), p.e007722-e007722
Hauptverfasser: Gulati, Ankur, Japp, Alan G, Raza, Sadaf, Halliday, Brian P, Jones, Daniel A, Newsome, Simon, Ismail, Nizar A, Morarji, Kishen, Khwaja, Jahanzaib, Spath, Nick, Shakespeare, Carl, Kalra, Paul R, Lloyd, Guy, Mathur, Anthony, Cleland, John G F, Cowie, Martin R, Assomull, Ravi G, Pennell, Dudley J, Ismail, Tevfik F, Prasad, Sanjay K
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Myocardial fibrosis, identified by late gadolinium enhancement cardiovascular magnetic resonance, predicts outcomes in chronic heart failure (HF). Its prognostic significance in new-onset HF and reduced left ventricular ejection fraction (LVEF) is unclear. We investigated whether the pattern and extent of fibrosis predict survival in new-onset HF and reduced LVEF of initially uncertain pathogenesis. Of 120 consecutive patients with new-onset (
ISSN:1942-0080
DOI:10.1161/circimaging.118.007722